期刊文献+

终末期糖尿病肾病血液透析危险因素分析及护理对策 被引量:2

Risk Factors and Nursing Strategies for Patients with End Stage Diabetic Nephropathy Undergoing Hemodialysis
下载PDF
导出
摘要 目的探讨影响终末期糖尿病肾病(DN)血液透析患者生活质量和长期存活的各种危险因素及护理对策。方法选择38例终末期DN血液透析患者和同期38例相同各年龄段非糖尿病血液透析患者,分别观察血生化改变、存活率、内瘘使用情况及并发症。结果DN组1年和2年存活率分别为76.3%和60.5%;主要并发症是高血压、心力衰竭、心律失常、感染、透析时低血压,与非DN组比较有显著性差异。结论终末期DN患者较非糖尿病患者应更早进行血透;加强护理,减少并发症发生是提高生活质量和长期存活的关键。 Objective To investigate the risk factors that influence the quality of life and survival time of the end stage diabetic nephropathy (ESDN) patients undergoing hemodialysis, as well as the nursing measures. Methods 38 cases of hemodialysis patients with ESDN in the DN group were observed on the changes of blood biochemical indexes, survival rate, status of internal fistula and complications. 38 cases of hemodialysis patients without DN with the same age at the same period in the non-DN group were taken as the control. Results The one-year survival rate and two year-survival rate in the DN group were 76.3% and 60.5% retrospectively. The main complications in patients with DN were hypertension, heart failure, cardiac arrhythmia, infections, intradialytic hypotension. There were significantly differences between the two groups. Conclusions Early dialysis and appropriate nursing measures play an important role in improving the quality of life and prolonging survival time in hemodialysis patients with DN.
作者 汪吉平
出处 《临床护理杂志》 2006年第3期16-18,共3页 Journal of Clinical Nursing
关键词 糖尿病肾病/护理 血液透析滤过/护理 危险因素 diabetic nephropathies/nursing hemodiafitration/nursing risk factors
  • 相关文献

参考文献3

二级参考文献9

共引文献32

同被引文献20

  • 1马新美,王继军.54例糖尿病肾病患者内瘘建立与使用的体会[J].中国血液净化,2004,3(12):692-692. 被引量:13
  • 2王成付,洪永刚,余家福,何晓旋,杨海燕,张慧琴.鼻咽窝两种不同术式建立动静脉内瘘的临床研究[J].中国血液净化,2005,4(8):455-456. 被引量:4
  • 3苗金红,王俊平,李肖静.护理干预对糖尿病肾病腹膜透析患者营养不良的影响[J].中国误诊学杂志,2007,7(6):1375-1376. 被引量:13
  • 4Kimmel PL, Varela MP, Peterson RA, et al. Inerdialytic weight gain and survival in hemodialysis patients : effects of duration of ESRD and diabe- tes mellitus [J] . Kidney Int, 2000, 57 (3) : 1141-1151.
  • 5Pietrzak B. Ophthalmologic complications in patients with diabetic ne- phropathy treated with peritoneal dialysis [ J ] . Pol Merkur Lekai"ski, 2004, 17 (98): 180-182.
  • 6Tsuchida K, Makita Z, Yamagishi S, et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic ne- phropathy in rats by a novel advanced gyration end product inhibitor, OPB-9195 [J]. Diabetologia, 1999, 42 (5):579-584.
  • 7Goh SY, Cooper ME. Clinical review : The role of advanced glycation end products in progression and complications of diabetes [ J] . J Clin Endo- crinol Metab, 2008, 93 (4) : 1143-1152.
  • 8Hara S, Katori H, Ubara Y. Dialysis therapy and problem for renal fail- ure of diabetic nephropathy [ J] . Nihon Rinsho, 2002, 60 ( 10 ) : 306-315.
  • 9Iyengar SK, Abboud HE, Goddard KA, et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND) [ J] . Diabe- tes, 2007, 56 (6): 1577-1585.
  • 10Khalifah RG, Chen Y, Wassenberg JJ. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design [ J] . Ann N Y Aead Sei, 2005, 1043 (1) : 793-806.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部